chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got Covid 19 a few days after my first shot. Test  positive on 09Mar; This is a spontaneous report received from a contactable consumer (patient). A 60-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: En6203 and Expiration date not reported) via an unspecified route of administration, in Arm left, on 03Mar2021 (at the age of 60 years) as a 1st dose, single for covid-19 immunization. The patient medical history included diabetes, hypertension and UTI (Urinary tract infection). Concomitant medications included acyclovir [ACICLOVIR] taken for an unspecified indication and ambroxol hydrochloride (ABX) taken for urinary tract infection, for both start and stop date were not reported. Other medications the patient received within 2 weeks of vaccination includes Abx for UTI. The patient received some other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19. On 09Mar2021, she got COVID-19 a few days after her first shot. The adverse event result in Doctor or other healthcare professional office/clinic visit. It was unknown if treatment was received for the event. The patient underwent lab tests and procedures which included Nasal Swab sars-cov-2 test: positive on 09Mar2021. Outcome of the event was reported as recovering.  No follow-up attempts are needed. No further information is expected.
Vertigo; Dizziness; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced vertigo. On APR-2021, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from vertigo, and dizziness. This report was non-serious.
pt recv vax & devel a breakthrough case of chickenpox w/approx 20 vesicles;pt seen by MD who described the vesicles as red w/clear liquid drew drop on a rose petal;
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date in August 2017, the patients were vaccinated with ZOSTAVAX lot # N016185, expiration date 31-JUL-2018. Concomitant therapies included sterile diluent. On an unknown date in August 2017, the patients experienced incorrect product storage. Additional information has been requested. Sender's Comments: US-009507513-1708USA012778.
Case number PHEH2013US025304 is an initial spontaneous report received from a nurse on 04 Dec 2013 and a follow up report from the nurse received on 31 Dec 2013: This report refers to a 17-year-old male patient. His previous vaccinations included DTaP on 05 Dec 1996, 06 Feb 1997, 24 Apr 1997, 23 Jul 1999, 21 Aug 2000, 15 Aug 2001 and 08 Nov 2011, Polio vaccine (unknown manufacturer) on 05 Dec 1996, 06 Feb 1997, 23 Jul 1999 and 15 Aug 2001, MMR (other manufacturer) on 23 Jul 1999 and 15 Aug 2001, Hib on 05 Dec 1996, 06 Feb 1997 and 21 Aug 2000, hepatitis B vaccine on 10 Oct 1996, 05 Dec 1996 and 26 Apr 1997, Varicella vaccine on 08 Nov 2011 and 10 Jan 2012. HPV on 10 Jan 2012, seasonal influenza vaccine on 06 Nov 2009, 08 Nov 2011 and on 20 Sep 2013, meningococcal conjugate on 08 Nov 2011 and H1N1 influenza vaccine on 06 Nov 2009. Concomitant vaccine included GARDASIL (other manufacturer, batch number: J008423) received on 02 Dec 2013. He was given only MenCYW liquid component of MENVEO (batch number: X12124) mixed with sterile water, intramuscularly on 02 Dec 2013 (at 4:30 pm). No adverse event was reported following this administration error. Follow up report from the nurse received on 31 Dec 2013: Vaccination history and concomitant vaccine were added. Updated vaccination site and time.
Could not move the left arm after 2nd shot; Swollen deltoid muscle left arm after 2nd shot; Generalized body ache after 2nd shot; Redness at site of injection after 2nd shot; Fever low grade 100.1 F after 2nd shot; This spontaneous case was reported by a physician and describes the occurrence of MOBILITY DECREASED (Could not move the left arm after 2nd shot), VACCINATION SITE SWELLING (Swollen deltoid muscle left arm after 2nd shot), MYALGIA (Generalized body ache after 2nd shot), VACCINATION SITE ERYTHEMA (Redness at site of injection after 2nd shot) and PYREXIA (Fever low grade 100.1 F after 2nd shot) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced MOBILITY DECREASED (Could not move the left arm after 2nd shot), VACCINATION SITE SWELLING (Swollen deltoid muscle left arm after 2nd shot), MYALGIA (Generalized body ache after 2nd shot), VACCINATION SITE ERYTHEMA (Redness at site of injection after 2nd shot) and PYREXIA (Fever low grade 100.1 F after 2nd shot). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. On 29-Jan-2021, MOBILITY DECREASED (Could not move the left arm after 2nd shot), VACCINATION SITE SWELLING (Swollen deltoid muscle left arm after 2nd shot), MYALGIA (Generalized body ache after 2nd shot), VACCINATION SITE ERYTHEMA (Redness at site of injection after 2nd shot) and PYREXIA (Fever low grade 100.1 F after 2nd shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, Body temperature: 100.1 (High) low grade fever 100.1 Fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.  After second shot, patient had a swollen deltoid muscle left arm, could not move the arm, generalized body ache, redness at site of injection and low grade fever 100.1 Fahrenheit. Patient took Tylenol and the reaction went away after 2 days.   This case was linked to MOD-2021-406527, MOD-2021-406569 (Patient Link).
Information has been received from a medical assistant and a physician concerning a 22 year old female with no medical history or drug allergies who on 01-APR-2010 was vaccinated with the first dose of GARDASIL (lot # 661954/0075Y), 0.5ml, IM. Concomitant therapy included MENACTRA and HAVRIX. The medical assistant reported that on 01-APR-2010 the patient experienced a seizure within seconds after receiving GARDASIL. The patient was taken to an emergency room and was given intravenous fluid. However, when intravenous fluid was stopped, another seizure occurred and she fell to the floor. The patient recovered on 01-APR-2010 and went home. The physician confirmed that the patient fell on her head after receiving GARDASIL. The patient went to the emergency room and was given an IV. The IV was removed and the patient got up to leave and fell on the back of her head. The patient had syncope occur twice in a 24 hour period. The patient recovered on 01-APR-2010. Upon internal review, seizure was determined to be an other important medical event. Additional information has been requested.
At approximately 4 hours post-booster dose of COVID-19 vaccine the patient developed a single hive with redness and itching at vaccination site.  She denies any shortness of breath, no tongue or lip swelling, nor generalized symptoms.  Patient self treated with 10 mg of Zyrtec and returned to clinic.  She was given 25 mg of Benedryl orally and started on Famotidine 20 mg orally.  She was observed over the course of an hour with slight decrease of the size of hive and no new symptoms.
After the booster my mom had periods of rapid heartbeat. She says it feels like guttering. It is now March and she still is getting them although not as frequent. She had gone through many tests at the cardiologists and all were ok.
Suspected Vaccination Failure; have had shingles twice and I have been vaccinated twice; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient had shingles twice and the patient had been vaccinated twice. The patient asked what should they have to make this commercial. This case was considered as suspected vaccination failure, since the details regarding the time to onset for event and laboratory confirmation for influenza were not provided.
He had a bad cough, and it went on for about four days. He was also sneezing and very congested. I gave him over the counter cetirizine. He wasn't getting better, so I contacted his doctor. He suggested that I give him BURT'S BEES cough medication. He is still coughing and sneezing at this time.
Initial misuse report received from a healthcare professional on 26 September 2013. The case was received on 21 March 2014 at agency. A child had received fifth dose of PENTACEL in the DTaP series. No adverse event was reported. List of documents held by sender: none.
Patient with history of anaphylactic reaction to chemotherapy 9 years ago presents for 1st dose of covid vaccination. She brought her epi pen with her today. Discussed risks and benefits of vaccine, patient accepts risks and received vaccine. 15 minutes later she developed tingling sensation in throat, denied SOB,  wheezing, tongue swelling, stridor, skin rash, chest pain, nausea/vomiting, tachycardia. She was assessed by MD and NP on site. Administered 25 mg of benadryl PO. Vital signs were monitored every 5 minutes for 30 minutes by paramedic on scene. Vital signs were stable throughout assessment. BP slightly elevated during exam. Continued to monitor for another 30 minutes. Patient denies tingling sensation, any SOB, CP, wheezing following 60 minutes total of monitoring. Physical assessment unremarkable. Lungs clear to auscultation, heart rate regular.
Fever 104.2, , shortness of breath, cough-lasting 24hrs Severe body aches/cramps, rash red raised and warm to touch approximately 6"x4" (upper arm)-still experiencing at approx 48hrs
injection site reaction that spread to neck, arm and across chest. Skin was red, itchy and rough.
Information has been received from a physician concerning a 29 year old white female with hypothyroidism and migraine headache and no previous pregnancy. In April-2007, the first ultrasound was performed for fetal survey. On 20-APR-2007, serum alpha-fetoprotein test was performed for screening and the result was normal. On 04-JUN-2007, the second ultrasound was performed for fetal survey. On 06-AUG-2007 the patient was vaccinated with a dose of GARDASIL when she was 29 weeks pregnant. The patient received the vaccine in error and was supposed to receive RHOGAM. Concomitant therapy included SYNTHROID and prenatal vitamins. On 16-AUG-2007 and 27-SEP-2007, separate ultrasound was performed. On 01-NOV-2007 the patient delivered a health normal baby boy at 41.2 weeks gestation. The weight of the baby was 8.0 pounds; the length was 21 inches; the Apgar score was 9/9. There was no congenital anomaly or complication with the baby. Additional information is not expected.
A couple hours after receiving vaccine, bumped back of deltoid and noticed had a painful boil. The boil wasn't at the vaccination site. Hasn't subsided over 2 weeks. Hasn't tried any other remedies. Hasn't tried anything to improve it. No pus so hasn't tried to pop it.
Mild rash on neck and chest. Saw Allergist 2 days after. They said not to get second Pfizer vaccine. Going back in 3 weeks to test to see if allergic to Johnson and Johnson vaccine components.
Pain; Swollen; On right arm she has a 3 inch long and 2 inches wide lymph nodes that is painful and swollen.; On right arm she has a 3 inch long and 2 inches wide lymph nodes that is swollen.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), SWELLING (Swollen), LYMPH NODE PAIN (On right arm she has a 3 inch long and 2 inches wide lymph nodes that is painful and swollen.) and LYMPHADENOPATHY (On right arm she has a 3 inch long and 2 inches wide lymph nodes that is swollen.) in a 56-year-old female patient who received mRNA-1273 (COVID-19 Vaccine Moderna) (batch nos. 048B21A and 017B21A) for COVID-19 vaccine.     No medical history was provided by the reporter.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (COVID-19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (COVID-19 Vaccine Moderna) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Pain), SWELLING (Swollen), LYMPH NODE PAIN (On right arm she has a 3 inch long and 2 inches wide lymph nodes that is painful and swollen.) and LYMPHADENOPATHY (On right arm she has a 3 inch long and 2 inches wide lymph nodes that is swollen.). At the time of the report, PAIN (Pain), SWELLING (Swollen), LYMPH NODE PAIN (On right arm she has a 3 inch long and 2 inches wide lymph nodes that is painful and swollen.) and LYMPHADENOPATHY (On right arm she has a 3 inch long and 2 inches wide lymph nodes that is swollen.) outcome was unknown.            no concomitant details reported. no treatment details reported.
Information has been received from a licensed practical nurse concerning an 18 year old female with no pertinent medical history and no history of drug reaction or allergies who on 02-JUN-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast) (lot#: 660391/0063X) and on 25-JUN-2008 was vaccinated with the second dose of GARDASIL vaccine (yeast). There was no concomitant medication. After the first vaccination the patient developed a fever. After the second vaccination the patient developed stomach cramps and diarrhea which lasted for a week. Subsequently, the patient recovered. The patient sought medical attention with a phone call. Additional information has been requested.
Pt. states that after receiving the 1st dose of High-Dose Influenza 11/12/2021, started experiencing symptoms that evening of nausea, vomiting, muscle aches, and fatigue. Lasting 24 hours, Primary communications * still waiting for recommendations.
ACCORDING TO DAUGHTER, SEVERE RASH, SWOLLEN INJECTION SITE, HEADACHE, FEVER, CHILLS, BODY ACHE, LOUD RINGING IN THE EARS FOR ABOUT 3 DAYS.
pt recvd vax 7NOV94 & that afternoon, coincidentally had blood drawn & was found to have an elevated SGPT level;
Hive like rash on neck, face, and right ear. Itching 2 days. Doctor rec. Diphenhydramine.
Patient admitted to Hospital for blood clot in lung after falling twice approximately 24 hours after 2nd COVID immunization
the patient experienced flushing, dizziness, palor, erythema and visual impairment after receiving the vaccines; the patient experienced flushing, dizziness, palor, erythema and visual impairment after receiving the vaccines; the patient experienced flushing, dizziness, palor, erythema and visual impairment after receiving the vaccines; the patient experienced flushing, dizziness, palor, erythema and visual impairment after receiving the vaccines; blood pressure was fluctuating; the patient experienced flushing, dizziness, palor, erythema and visual impairment after receiving the vaccines; This spontaneous report was received from a nurse referring to a male patient of unknown age. The patient's concurrent conditions, medical history, concomitant medications and drug reactions/allergies were unknown. On an unknown date in March 2018 the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, strength, lot# and expiration date were not reported), meningococcal acyw conj vaccine (dip toxoid) (MENACTRA) and diphtheria toxoid, pertussis acellular 5-component vaccine, tetanus toxoid (ADACEL) (doses, strengths, lot # and expiration dates of all products were unknown) all via intramuscular route as routine vaccines and patient experienced flushing, dizziness, pallor, erythema and visual impairment after receiving the vaccines and was transported by an ambulance to an unknown hospital but the patient was not admitted, as his blood pressure was fluctuating (blood pressure fluctuation). It was also reported that the ambulance may put the patient on oxygen. No overdose and product quality complaint (PQC) involved. The outcome of events was unknown. The reporter's causality assessment between the events and the suspect therapies was not provided.  The reporter considered all the events as medically significant.  This case has been cross linked to 1907USA002813 (sibling case).
Information has been received from a physician concerning a 12 year old female patient who 2 weeks ago (on approximately 11-AUG-2009), was vaccinated with the first dose of GARDASIL. One week after vaccination (on approximately 18-AUG-2009) the patient had an outbreak of plantar warts. The plantar warts were on both knees, fingers on both hands, both elbows and both feet. The patient's outbreak of plantar wart persisted. The patient sought medical attention by visit to an unspecified dermatologist. No further information is available.
On 3/12/09 Tetanus/Diptheria toxoid was given in the left arm along with influenza and pneumonia which were given in the right arm.  That night the patient complained of left arm swelling and not feeling well along with a fever.  On 3/16/09 pt has large area on left upper arm red,itchy, hot and swollen.  There is a 4inch bruised area around the injection site.  She no longer has a fever.
RECIEVED INJECTION ON 06-21-05. NEXT DAY, PATIENT C/O MALAISE, HEADACHES, FEVER (100.4F). PATIENT USED TYLENOL, MOTRIN AND INCREASED FLUIDS INSTRUCTED TO FOLLOW UP WITH DOCTOR IF NO BETTER. SEEN BY PHYSICIAN ON 06-24-05 WITH PERSISTANT ACHES AND PAIN IN JOINTS AND BACK. C/O DECREASED APPETITE. PATIENT DENIES N/V/D/C, ALSO DENIES VISUAL PROBLEMS, WEAKNESS AND PARASTHESIAS.
I frequently get Pneumonia; I have Advanced COPD. On 12/24/2022 I first started feeling the symptoms. I felt completely awful, I was very sick. I had continuous fever, and I felt often as if I could not breath. It was like my lungs were slowly collapsing. I went to the ER and was given antibiotics, oxygen and fluids.
Approximately April 16 (2 weeks after second shot)  Left leg went out from under me unexpectledly. Few days later happened again but continued to be weaker and Blood pressure increased to 207/140 while I was out shopping. Drove myself to hospital ER and they admitted me. from 04/26 to 04/29. On 04/29 they did MRI brain scan and determined that I had suffered a right quadron brain bleed which left me left side leg weakness and balance issues. Sent me home on 04/29 and told me see primary Dr. right away.. They ordered in home therapy for a few weeks and in 2 weeks I start outpatient therapy . Since this 3 of my Dr's agreed to have a Heart loop monitor inserted in my chest which I agreed to. Staples come out next week.
rash on face/chest 25JUL96 w/inc temp;26JUL96 rash inc-temp nl;
Approximately 2 weeks after the 2nd dose of the pheizer vaccine,  I started experiencing vertigo,  and a massive lack of energy.  Sometimes it gets so bad,  I have to sit down because it feels like I'm going to collapse.  I have also experienced chest pains in the first month after the second shot,  but these have seemed to go away.  The tired and vertigo sensations are ongoing months after the shot.
PT WAS ADMINISTERED INCORRECT DOSE FOR PRIMARY DOSING SERIES. GIVEN 0.5mL INSTEAD OF RECOMMENDED 0.25 mL FOR THIS MODERNA VACCINE LOT NUMBER. NO TREATMENT NECESSARY, NO OBSERVED OUTCOMES OR SYMPTOMS.
After 4 hours: severe stomach pain (exploded with diarrhea), cold sweats, chilled, shivering, dizzy, had tie on the floor prior to coming up stairs, laid down with blanket covering me, had to add two more blankets to stop shivering, head ache, felt like vomiting but did not, arm at point of injection was very sore, fell asleep, upon wakening after another two hours my entire body was aching, ate a high protein meal, went to bed at 10:00 PM - next morning my entire body was aching - like someone beat me - was very tired after being up for five hours. At present I'm feeling much better but sore in many areas.
bell's palsy; A spontaneous report from was received from a Consumer concerning a 62-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Bells palsy.    The patient had a history of Bells palsy in the last five years. No relevant concomitant medications were reported.    On 07 Mar 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 25 Mar 2021, the patient experienced the event Bells palsy.   Laboratory details was not provided.  Treatment medication included prednisone and valacyclovir.   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event of facial paralysis, a causal relationship cannot be excluded. Patient's prior history of Bell's palsy is considered a risk factor.
Patient developed transient synovitis. She was admitted to the hospital for treatment. Sent home with Rx for ZANTAC and instructions to take ibuprofen prn.
This spontaneous report was received from a nurse regarding unspecified patients of unknown age and gender. Pertinent medical histories, drug reactions or allergies and concomitant therapies of the patients' were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB lot # L033690, expiration date 14-JUN-2018 (dose and route of administration were not reported). The administered doses experienced a temperature excursion of 0.0 degree Celsius for 9 hours. Previous excursions were 1.4 degree Celsius for 14 minutes, 0.0 C for 11 hours and 43 minutes,0.7 degree Celsius for 12 hours and 53 minutes 0.0 degree Celsius for 10 hours and 36 minutes, 0.6 degree Celsius for 46 minutes and 32 degree Fahrenheit for 4 hour and 20 minutes. The temperature excursions were detected by a data logger. No adverse effects were reported. There was no product quality complaint (PQC) involved. This is one of three reports received from the same reporter. Additional information has been requested.